Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang & Iain D. G. Campuzano. (2023) Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies. mAbs 15:1.
Read now
Read now
Jonathan Zarzar, Tarik Khan, Maniraj Bhagawati, Benjamin Weiche, Jasmin Sydow-Andersen & Alavattam Sreedhara. (2023) High concentration formulation developability approaches and considerations. mAbs 15:1.
Read now
Read now
Tushar Jain, Todd Boland & Maximiliano Vásquez. (2023) Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches. mAbs 15:1.
Read now
Read now
Carl Mieczkowski, Xuejin Zhang, Dana Lee, Khanh Nguyen, Wei Lv, Yanling Wang, Yue Zhang, Jackie Way & Jean-Michel Gries. (2023) Blueprint for antibody biologics developability. mAbs 15:1.
Read now
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Jonathan Schmitt, Abbas Razvi & Christoph Grapentin. (2023) Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks. mAbs 15:1.
Read now
Read now
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P. Humphreys & Sam P. Heywood. (2023) TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15:1.
Read now
Read now
Marco A. Blanco. (2022) Computational models for studying physical instabilities in high concentration biotherapeutic formulations. mAbs 14:1.
Read now
Read now
Pin-Kuang Lai, Austin Gallegos, Neil Mody, Hasige A. Sathish & Bernhardt L. Trout. (2022) Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics. mAbs 14:1.
Read now
Read now
Rahmad Akbar, Habib Bashour, Puneet Rawat, Philippe A. Robert, Eva Smorodina, Tudor-Stefan Cotet, Karine Flem-Karlsen, Robert Frank, Brij Bhushan Mehta, Mai Ha Vu, Talip Zengin, Jose Gutierrez-Marcos, Fridtjof Lund-Johansen, Jan Terje Andersen & Victor Greiff. (2022) Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. mAbs 14:1.
Read now
Read now
Nels Thorsteinson, John R. Gunn, Kenneth Kelly, Will Long & Paul Labute. (2021) Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeutics. mAbs 13:1.
Read now
Read now
Emily K. Makowski, Lina Wu, Priyanka Gupta & Peter M. Tessier. (2021) Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13:1.
Read now
Read now
Joschka Bauer, Sven Mathias, Sebastian Kube, Kerstin Otte, Patrick Garidel, Martin Gamer, Michaela Blech, Simon Fischer & Anne R Karow-Zwick. (2020) Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain. mAbs 12:1.
Read now
Read now
Marc Bailly, Carl Mieczkowski, Veronica Juan, Essam Metwally, Daniela Tomazela, Jeanne Baker, Makiko Uchida, Ester Kofman, Fahimeh Raoufi, Soha Motlagh, Yao Yu, Jihea Park, Smita Raghava, John Welsh, Michael Rauscher, Gopalan Raghunathan, Mark Hsieh, Yi-Ling Chen, Hang Thu Nguyen, Nhung Nguyen, Dan Cipriano & Laurence Fayadat-Dilman. (2020) Predicting Antibody Developability Profiles Through Early Stage Discovery Screening. mAbs 12:1.
Read now
Read now
Kannan Sankar, Kam Hon Hoi, Yizhou Yin, Prasanna Ramachandran, Nisana Andersen, Amy Hilderbrand, Paul McDonald, Christoph Spiess & Qing Zhang. (2018) Prediction of methionine oxidation risk in monoclonal antibodies using a machine learning method. mAbs 10:8, pages 1281-1290.
Read now
Read now
Arif Jetha, Nels Thorsteinson, Yazen Jmeian, Ajitha Jeganathan, Patricia Giblin & Johan Fransson. (2018) Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies. mAbs 10:6, pages 890-900.
Read now
Read now
Articles from other publishers (44)
Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh & Jeremy D. Schmit. (2023) Prediction of Antibody Viscosity from Dilute Solution Measurements. Antibodies 12:4, pages 78.
Crossref
Crossref
Amjad A. Chowdhury, Neha Manohar, Alfredo Lanzaro, William D. Kimball, Marta A. Witek, Mahlet A. Woldeyes, Ranajoy Majumdar, Ken K. Qian, Shifeng Xu, Richard E. Gillilan, Qingqiu Huang, Thomas M. Truskett & Keith P. Johnston. (2023) Characterizing Protein–Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics Simulations. Molecular Pharmaceutics 20:11, pages 5563-5578.
Crossref
Crossref
Emily K. Makowski, Tiexin Wang, Jennifer M. Zupancic, Jie Huang, Lina Wu, John S. Schardt, Anne S. De Groot, Stephanie L. Elkins, William D. Martin & Peter M. Tessier. (2023) Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature Biomedical Engineering.
Crossref
Crossref
Ilaria Mosca, Kévin Pounot, Christian Beck, Louise Colin, Olga Matsarskaia, Christoph Grapentin, Tilo Seydel & Frank Schreiber. (2023) Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions. Molecular Pharmaceutics 20:9, pages 4698-4713.
Crossref
Crossref
Carl A. Mieczkowski. (2023) The Evolution of Commercial Antibody Formulations. Journal of Pharmaceutical Sciences 112:7, pages 1801-1810.
Crossref
Crossref
Amjad A. Chowdhury, Neha Manohar, Marta A. Witek, Mahlet A. Woldeyes, Ranajoy Majumdar, Ken K. Qian, William D. Kimball, Shifeng Xu, Alfredo Lanzaro, Thomas M. Truskett & Keith P. Johnston. (2023) Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High Concentrations. Molecular Pharmaceutics 20:6, pages 2991-3008.
Crossref
Crossref
Brajesh K. Rai, James R. Apgar & Eric M. Bennett. (2023) Low-data interpretable deep learning prediction of antibody viscosity using a biophysically meaningful representation. Scientific Reports 13:1.
Crossref
Crossref
Amjad Chowdhury, Neha Manohar, Geetika Guruprasad, Amy T. Chen, Alfredo Lanzaro, Marco Blanco, Keith P. Johnston & Thomas M. Truskett. (2023) Characterizing Experimental Monoclonal Antibody Interactions and Clustering Using a Coarse-Grained Simulation Library and a Viscosity Model. The Journal of Physical Chemistry B 127:5, pages 1120-1137.
Crossref
Crossref
Preeti G. Desai, Patrick Garidel, Francisca O. Gbormittah, Douglas E. Kamen, Brittney J. Mills, Chakravarthy N. Narasimhan, Shubhadra Singh, Elaine S.E. Stokes & Erika R. Walsh. (2023) An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations. Journal of Pharmaceutical Sciences 112:2, pages 359-369.
Crossref
Crossref
Zhidong Chen, Xinpei Wang, Xu Chen, Juyang Huang, Chenglin Wang, Junqing Wang & Zhe Wang. (2023) Accelerating therapeutic protein design with computational approaches toward the clinical stage. Computational and Structural Biotechnology Journal 21, pages 2909-2926.
Crossref
Crossref
Nels Thorsteinson, Stephen R. ComeauJrJr & Sandeep Kumar. 2023. Computer-Aided Antibody Design. Computer-Aided Antibody Design
219
235
.
Takuya ShimomuraMitsuhiro SekiguchiReisa HondaMiki YamazakiMasami Yokoyama & Susumu Uchiyama. (2022) Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter. Biological and Pharmaceutical Bulletin 45:9, pages 1300-1305.
Crossref
Crossref
Kannan Sankar, Kyle Trainor, Levi L. Blazer, Jarrett J. Adams, Sachdev S. Sidhu, Tyler Day, Elizabeth Meiering & Johannes K. X. Maier. (2022) A Descriptor Set for Quantitative Structure‐property Relationship Prediction in Biologics. Molecular Informatics 41:9.
Crossref
Crossref
Emily K. Makowski, Patrick C. Kinnunen, Jie Huang, Lina Wu, Matthew D. Smith, Tiexin Wang, Alec A. Desai, Craig N. Streu, Yulei Zhang, Jennifer M. Zupancic, John S. Schardt, Jennifer J. Linderman & Peter M. Tessier. (2022) Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space. Nature Communications 13:1.
Crossref
Crossref
W Jiskoot, Andrea Hawe, Tim Menzen, David B. Volkin & Daan J.A. Crommelin. (2022) Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?. Journal of Pharmaceutical Sciences 111:4, pages 861-867.
Crossref
Crossref
Dheeraj S. Tomar, Giuseppe Licari, Joschka Bauer, Satish K. Singh, Li Li & Sandeep Kumar. (2022) Stress-dependent Flexibility of a Full-length Human Monoclonal Antibody: Insights from Molecular Dynamics to Support Biopharmaceutical Development. Journal of Pharmaceutical Sciences 111:3, pages 628-637.
Crossref
Crossref
Subhabrata Majumder, Deep S. Bhattacharya, Alex Langford & Arun Alphonse Ignatius. (2022) Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies. Pharmaceutical Research 39:3, pages 529-539.
Crossref
Crossref
Pin-Kuang Lai. (2022) DeepSCM: An efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity. Computational and Structural Biotechnology Journal 20, pages 2143-2152.
Crossref
Crossref
Adriana-Michelle Wolf Pérez, Nikolai Lorenzen, Michele Vendruscolo & Pietro Sormanni. 2022. Therapeutic Antibodies. Therapeutic Antibodies
57
113
.
Lucky Ahmed, Priyanka Gupta, Kyle P. Martin, Justin M. Scheer, Andrew E. Nixon & Sandeep Kumar. (2021) Intrinsic physicochemical profile of marketed antibody-based biotherapeutics. Proceedings of the National Academy of Sciences 118:37.
Crossref
Crossref
Pin-Kuang Lai, Amendra Fernando, Theresa K. Cloutier, Jonathan S. Kingsbury, Yatin Gokarn, Kevin T. Halloran, Cesar Calero-Rubio & Bernhardt L. Trout. (2021) Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation. Journal of Pharmaceutical Sciences 110:4, pages 1583-1591.
Crossref
Crossref
Pin-Kuang Lai, Amendra Fernando, Theresa K. Cloutier, Yatin Gokarn, Jifeng Zhang, Walter Schwenger, Ravi Chari, Cesar Calero-Rubio & Bernhardt L. Trout. (2021) Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies. Molecular Pharmaceutics 18:3, pages 1167-1175.
Crossref
Crossref
Cindy D. Ren, Wei Qi, Emily A. Wyatt, Jeffrey Yeary, Kimberly Westland, Michael Berke & Nitin Rathore. (2021) Application of a High Throughput and Automated Workflow to Therapeutic Protein Formulation Development. Journal of Pharmaceutical Sciences 110:3, pages 1130-1141.
Crossref
Crossref
Tim J. Kamerzell & C. Russell Middaugh. (2021) Prediction Machines: Applied Machine Learning for Therapeutic Protein Design and Development. Journal of Pharmaceutical Sciences 110:2, pages 665-681.
Crossref
Crossref
Franz Waibl, Monica L. Fernández-Quintero, Anna S. Kamenik, Johannes Kraml, Florian Hofer, Hubert Kettenberger, Guy Georges & Klaus R. Liedl. (2021) Conformational Ensembles of Antibodies Determine Their Hydrophobicity. Biophysical Journal 120:1, pages 143-157.
Crossref
Crossref
Manali S. Sawant, Craig N. Streu, Lina Wu & Peter M. Tessier. (2020) Toward Drug-Like Multispecific Antibodies by Design. International Journal of Molecular Sciences 21:20, pages 7496.
Crossref
Crossref
Richard A Norman, Francesco Ambrosetti, Alexandre M J J Bonvin, Lucy J Colwell, Sebastian Kelm, Sandeep Kumar & Konrad Krawczyk. (2020) Computational approaches to therapeutic antibody design: established methods and emerging trends. Briefings in Bioinformatics 21:5, pages 1549-1567.
Crossref
Crossref
Vishnu Jayaprakash, Maxime Costalonga, Somayajulu Dhulipala & Kripa K. Varanasi. (2020) Enhancing the Injectability of High Concentration Drug Formulations Using Core Annular Flows. Advanced Healthcare Materials 9:18.
Crossref
Crossref
Bing Zhou, Lin Xia, Tianying Zhang, Min You, Yang Huang, Maozhou He, Ruopeng Su, Jixian Tang, Juan Zhang, Shaowei Li, Zhiqiang An, Quan Yuan, Wenxin Luo & Ningshao Xia. (2020) Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development. Antiviral Research 180, pages 104757.
Crossref
Crossref
Jonathan Coffman, Bruno Marques, Raquel Orozco, Minni Aswath, Hasan Mohammad, Eike Zimmermann, Joelle Khouri, Jan Griesbach, Saeed Izadi, Ambrose Williams, Kannan Sankar, Benjamin Walters, Jasper Lin, Stefan Hepbildikler, John Schiel, John Welsh, Gisela Ferreira, Jared Delmar, Neil Mody, Christopher Afdahl, Tingting Cui, Rushd Khalaf, Alexander Hanke, Lars Pampel, Siddharth Parimal, Xuan Hong, Ujwal Patil, Jennifer Pollard, Francis Insaidoo, Julie Robinson, Divya Chandra, Marco Blanco, Jainik Panchal, Soundara Soundararajan, David Roush, Nihal Tugcu, Steven Cramer, Charles Haynes & Richard C. Willson. (2020) Highland games: A benchmarking exercise in predicting biophysical and drug properties of monoclonal antibodies from amino acid sequences. Biotechnology and Bioengineering 117:7, pages 2100-2115.
Crossref
Crossref
Saeed Izadi, Thomas W. Patapoff & Benjamin T. Walters. (2020) Multiscale Coarse-Grained Approach to Investigate Self-Association of Antibodies. Biophysical Journal 118:11, pages 2741-2754.
Crossref
Crossref
Erinc Sahin & Smeet Deshmukh. (2019) Challenges and Considerations in Development and Manufacturing of High Concentration Biologics Drug Products. Journal of Pharmaceutical Innovation 15:2, pages 255-267.
Crossref
Crossref
James R. Apgar, Amy S. P. Tam, Rhady Sorm, Sybille Moesta, Amy C. King, Han Yang, Kerry Kelleher, Denise Murphy, Aaron M. D’Antona, Guoying Yan, Xiaotian Zhong, Linette Rodriguez, Weijun Ma, Darren E. Ferguson, Gregory J. Carven, Eric M. Bennett & Laura Lin. (2020) Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. PLOS ONE 15:5, pages e0232713.
Crossref
Crossref
Daisuke Kuroda & Kouhei Tsumoto. (2020) Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design. Journal of Pharmaceutical Sciences 109:5, pages 1631-1651.
Crossref
Crossref
Duck Kyun Yoo, Seung Ryul Lee, Yushin Jung, Haejun Han, Hwa Kyoung Lee, Jerome Han, Soohyun Kim, Jisu Chae, Taehoon Ryu & Junho Chung. (2020) Machine Learning-Guided Prediction of Antigen-Reactive In Silico Clonotypes Based on Changes in Clonal Abundance through Bio-Panning. Biomolecules 10:3, pages 421.
Crossref
Crossref
Lorenzo Gentiluomo, Hristo L. Svilenov, Dillen Augustijn, Inas El Bialy, Maria Laura GrecoAlina Kulakova, Sowmya Indrakumar, Sujata Mahapatra, Marcello Martinez MoralesChristin Pohl, Aisling RocheAndreas Tosstorff, Robin Curtis, Jeremy P. Derrick, Allan Nørgaard, Tarik A. Khan, Günther H. J. Peters, Alain PluenÅsmund Rinnan, Werner W. Streicher, Christopher F. van der Walle, Shahid UddinGerhard Winter, Dierk Roessner, Pernille Harris & Wolfgang Frieß. (2020) Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization. Molecular Pharmaceutics.
Crossref
Crossref
Deniz B. Temel, Francis Kinderman & Ertan Eryilmaz. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
505
526
.
Bernardo Perez-Ramirez. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
49
69
.
Barton J. Dear, Jonathan A. Bollinger, Amjad Chowdhury, Jessica J. Hung, Logan R. Wilks, Carl A. Karouta, Kishan Ramachandran, Tony Y. Shay, Maria P. Nieto, Ayush Sharma, Jason K. Cheung, Dmytro Nykypanchuk, P. Douglas Godfrin, Keith P. Johnston & Thomas M. Truskett. (2019) X-ray Scattering and Coarse-Grained Simulations for Clustering and Interactions of Monoclonal Antibodies at High Concentrations. The Journal of Physical Chemistry B 123:25, pages 5274-5290.
Crossref
Crossref
Lu Shan, Neil Mody, Pietro SormaniKim L. Rosenthal, Melissa M. Damschroder & Reza Esfandiary. (2018) Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools. Molecular Pharmaceutics 15:12, pages 5697-5710.
Crossref
Crossref
Dheeraj S. Tomar, Satish K. Singh, Li Li, Matthew P. Broulidakis & Sandeep Kumar. (2018) In Silico Prediction of Diffusion Interaction Parameter (kD), a Key Indicator of Antibody Solution Behaviors. Pharmaceutical Research 35:10.
Crossref
Crossref
Margarida Viola, Joana Sequeira, Raquel Seiça, Francisco Veiga, João Serra, Ana C. Santos & António J. Ribeiro. (2018) Subcutaneous delivery of monoclonal antibodies: How do we get there?. Journal of Controlled Release 286, pages 301-314.
Crossref
Crossref
Sandeep Kumar, Kirk Roffi, Dheeraj S Tomar, David Cirelli, Nicholas Luksha, Danielle Meyer, Jeffrey Mitchell, Martin J Allen & Li Li. (2018) Rational optimization of a monoclonal antibody for simultaneous improvements in its solution properties and biological activity. Protein Engineering, Design and Selection 31:7-8, pages 313-325.
Crossref
Crossref
Alexander B. Kuhn, Sebastian Kube, Anne R. Karow-Zwick, Daniel Seeliger, Patrick Garidel, Michaela Blech & Lars V. Schäfer. (2017) Improved Solution-State Properties of Monoclonal Antibodies by Targeted Mutations. The Journal of Physical Chemistry B 121:48, pages 10818-10827.
Crossref
Crossref